These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 28382553)
61. Determinants of bone density in healthy older men with low testosterone levels. Kenny AM; Prestwood KM; Marcello KM; Raisz LG J Gerontol A Biol Sci Med Sci; 2000 Sep; 55(9):M492-7. PubMed ID: 10995046 [TBL] [Abstract][Full Text] [Related]
62. The relationship among serum lipocalin 2, bone turnover markers, and bone mineral density in outpatient women. Liu DM; Zhao HY; Zhao L; Zhang MJ; Liu TT; Tao B; Sun LH; Liu JM Endocrine; 2018 Feb; 59(2):304-310. PubMed ID: 29294226 [TBL] [Abstract][Full Text] [Related]
63. Nonstandard Lumbar Region in Predicting Fracture Risk. Alajlouni D; Bliuc D; Tran T; Pocock N; Nguyen TV; Eisman JA; Center JR J Clin Densitom; 2018; 21(2):220-226. PubMed ID: 28689879 [TBL] [Abstract][Full Text] [Related]
64. Association between hypertension and fragility fracture: a longitudinal study. Yang S; Nguyen ND; Center JR; Eisman JA; Nguyen TV Osteoporos Int; 2014 Jan; 25(1):97-103. PubMed ID: 23892585 [TBL] [Abstract][Full Text] [Related]
65. Pretreatment levels of bone turnover and the antifracture efficacy of alendronate: the fracture intervention trial. Bauer DC; Garnero P; Hochberg MC; Santora A; Delmas P; Ewing SK; Black DM; J Bone Miner Res; 2006 Feb; 21(2):292-9. PubMed ID: 16418785 [TBL] [Abstract][Full Text] [Related]
66. Bone Marrow-derived Endothelial Progenitor Cells Are Associated with Bone Mass and Strength. Cheng Q; Lin S; Bi B; Jiang X; Shi H; Fan Y; Lin W; Zhu Y; Yang F J Rheumatol; 2018 Dec; 45(12):1696-1704. PubMed ID: 30173148 [TBL] [Abstract][Full Text] [Related]
68. Serum levels of cross-linked N-telopeptides and aminoterminal propeptides of type I collagen indicate low bone mineral density in elderly women. Scariano JK; Glew RH; Bou-Serhal CE; Clemens JD; Garry PJ; Baumgartner RN Bone; 1998 Nov; 23(5):471-7. PubMed ID: 9823455 [TBL] [Abstract][Full Text] [Related]
69. The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group. Siris ES; Adler R; Bilezikian J; Bolognese M; Dawson-Hughes B; Favus MJ; Harris ST; Jan de Beur SM; Khosla S; Lane NE; Lindsay R; Nana AD; Orwoll ES; Saag K; Silverman S; Watts NB Osteoporos Int; 2014 May; 25(5):1439-43. PubMed ID: 24577348 [TBL] [Abstract][Full Text] [Related]
70. How hip and whole-body bone mineral density predict hip fracture in elderly women: the EPIDOS Prospective Study. Schott AM; Cormier C; Hans D; Favier F; Hausherr E; Dargent-Molina P; Delmas PD; Ribot C; Sebert JL; Breart G; Meunier PJ Osteoporos Int; 1998; 8(3):247-54. PubMed ID: 9797909 [TBL] [Abstract][Full Text] [Related]
71. Exercise and fractures in postmenopausal women. Final results of the controlled Erlangen Fitness and Osteoporosis Prevention Study (EFOPS). Kemmler W; Bebenek M; Kohl M; von Stengel S Osteoporos Int; 2015 Oct; 26(10):2491-9. PubMed ID: 25963237 [TBL] [Abstract][Full Text] [Related]
72. Calciotropic Hormones and the Prevalence of Vertebral Fractures in Chinese Postmenopausal Women with Vitamin D Insufficiency: Peking Vertebral Fracture Study. Jiajue R; Jiang Y; Qi X; Wang Q; Wang W; Pei Y; Wang X; Huang W; Zheng X; Ning Z; Wang O; Li M; Xing X; Yu W; Xu L; Xia W Calcif Tissue Int; 2019 Jun; 104(6):622-630. PubMed ID: 30737534 [TBL] [Abstract][Full Text] [Related]
73. Usefulness of daily teriparatide treatment in elderly patients over 80 years of age. Niimi R; Kono T; Nishihara A; Hasegawa M; Matsumine A; Kono T; Sudo A Osteoporos Int; 2016 May; 27(5):1869-74. PubMed ID: 26759334 [TBL] [Abstract][Full Text] [Related]
74. QCT of the proximal femur--which parameters should be measured to discriminate hip fracture? Museyko O; Bousson V; Adams J; Laredo J-; Engelke K Osteoporos Int; 2016 Mar; 27(3):1137-1147. PubMed ID: 26415934 [TBL] [Abstract][Full Text] [Related]
75. Association of red blood cell 5-methyltetrahydrofolate folate with bone mineral density in postmenopausal Iranian women. Golbahar J; Aminzadeh MA; Hamidi SA; Omrani GR Osteoporos Int; 2005 Dec; 16(12):1894-8. PubMed ID: 16133647 [TBL] [Abstract][Full Text] [Related]
76. Significant bone loss after stopping long-term denosumab treatment: a post FREEDOM study. Zanchetta MB; Boailchuk J; Massari F; Silveira F; Bogado C; Zanchetta JR Osteoporos Int; 2018 Jan; 29(1):41-47. PubMed ID: 28975362 [TBL] [Abstract][Full Text] [Related]
77. Biochemical Predictors of Low Bone Mineral Density and Fracture Susceptibility in Maltese Postmenopausal Women. Formosa MM; Xuereb-Anastasi A Calcif Tissue Int; 2016 Jan; 98(1):28-41. PubMed ID: 26400554 [TBL] [Abstract][Full Text] [Related]
78. Association of PFN1 Gene Polymorphisms with Bone Mineral Density, Bone Turnover Markers, and Osteoporotic Fractures in Chinese Population. Wu Y; Wu S; Yang E; Zhang G; Shi Q; Liang J; Lian X; Xu J Calcif Tissue Int; 2023 Aug; 113(2):207-215. PubMed ID: 37401976 [TBL] [Abstract][Full Text] [Related]
79. Soluble Tumor Necrosis Factor Alpha Receptor 1, Bone Resorption, and Bone Mineral Density in the Year Following Hip Fractures: The Baltimore Hip Studies. Salimi S; Shardell M; Miller R; Gruber-Baldini AL; Orwig D; Fedarko N; Hochberg MC; Guralnik JM; Magaziner J J Bone Miner Res; 2018 Sep; 33(9):1649-1656. PubMed ID: 29734462 [TBL] [Abstract][Full Text] [Related]
80. The value of osteopontin in the assessment of bone mineral density status in postmenopausal women. Fodor D; Bondor C; Albu A; Simon SP; Craciun A; Muntean L J Investig Med; 2013 Jan; 61(1):15-21. PubMed ID: 23117696 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]